JP7464348B2 - 血管新生を誘導する方法 - Google Patents

血管新生を誘導する方法 Download PDF

Info

Publication number
JP7464348B2
JP7464348B2 JP2016544820A JP2016544820A JP7464348B2 JP 7464348 B2 JP7464348 B2 JP 7464348B2 JP 2016544820 A JP2016544820 A JP 2016544820A JP 2016544820 A JP2016544820 A JP 2016544820A JP 7464348 B2 JP7464348 B2 JP 7464348B2
Authority
JP
Japan
Prior art keywords
tissue
angiogenesis
dhacm
amniotic membrane
placental tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016544820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017507114A5 (https=
JP2017507114A (ja
Inventor
ジェー． クーブ，トーマス
Original Assignee
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2017507114A publication Critical patent/JP2017507114A/ja
Publication of JP2017507114A5 publication Critical patent/JP2017507114A5/ja
Application granted granted Critical
Publication of JP7464348B2 publication Critical patent/JP7464348B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
JP2016544820A 2014-01-17 2015-01-20 血管新生を誘導する方法 Active JP7464348B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461928986P 2014-01-17 2014-01-17
US61/928,986 2014-01-17
PCT/US2015/012087 WO2015109329A1 (en) 2014-01-17 2015-01-20 Method for inducing angiogenesis

Publications (3)

Publication Number Publication Date
JP2017507114A JP2017507114A (ja) 2017-03-16
JP2017507114A5 JP2017507114A5 (https=) 2018-02-22
JP7464348B2 true JP7464348B2 (ja) 2024-04-09

Family

ID=53543554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016544820A Active JP7464348B2 (ja) 2014-01-17 2015-01-20 血管新生を誘導する方法

Country Status (5)

Country Link
US (3) US10052351B2 (https=)
EP (1) EP3094336A4 (https=)
JP (1) JP7464348B2 (https=)
AU (1) AU2015206236B2 (https=)
WO (1) WO2015109329A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
US10517931B2 (en) 2013-01-17 2019-12-31 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9827293B2 (en) 2013-01-17 2017-11-28 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en) 2013-01-17 2017-05-23 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
WO2015109329A1 (en) * 2014-01-17 2015-07-23 Mimedx Group, Inc. Method for inducing angiogenesis
US10894066B2 (en) * 2014-03-06 2021-01-19 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9814746B2 (en) * 2014-06-15 2017-11-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10363278B2 (en) 2014-06-15 2019-07-30 Amnio Technology Llc Frozen therapeutic dose and package
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
JP7391508B2 (ja) * 2015-09-03 2023-12-05 ミメディクス グループ インコーポレイテッド 胎盤増殖因子組成物の非外科的かつ限局的な送達
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
JP7011135B2 (ja) * 2016-02-19 2022-02-10 佳秀工業株式会社 血管内皮増殖因子産生促進剤の製造方法及び発毛剤の製造方法、並びに血管内皮増殖因子産生促進剤及び発毛剤
EP3471701A4 (en) * 2016-06-21 2020-02-19 The Regents of the University of California WOUND HEALING WITH BRAF INHIBITORS
WO2018140363A1 (en) * 2017-01-27 2018-08-02 Aziyo Biologics, Inc. Lyophilized placental composite sheet and uses thereof
US10743996B2 (en) * 2017-03-24 2020-08-18 Robert L. Bundy Amnion putty for cartilage repair
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3135546A1 (en) * 2019-04-04 2020-10-08 THT Biomaterials GmbH A novel human-material-based platform technology for tissue engineering
JP7684908B2 (ja) * 2019-04-16 2025-05-28 ライフネット ヘルス 出産組織由来の生成物並びにその調製及び使用
AU2021225836A1 (en) 2020-02-28 2022-09-15 Elutia Inc. Placental tissue compositions and methods
WO2024196980A1 (en) * 2023-03-22 2024-09-26 Wake Forest University Health Sciences Recombinant protein compositions useful for wound healing

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001161353A (ja) 1999-12-09 2001-06-19 Japan Ophthalmic Consultants:Kk 移植用細胞片及びその作成方法
JP2005519101A (ja) 2002-03-05 2005-06-30 ジェイモナト ソシエテ ペル アチオニ Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
JP2005218585A (ja) 2004-02-04 2005-08-18 National Institute For Materials Science 医療用材料及びその製造方法
WO2006025395A1 (ja) 2004-08-31 2006-03-09 Yasuhiko Shimizu キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
JP2008538180A (ja) 2005-03-31 2008-10-16 ステムニオン，インコーポレイテッド 羊膜由来細胞組成物、その作製方法および使用
JP2009514813A (ja) 2005-10-19 2009-04-09 センター フォー モレキュラー メディスン アンド イムノロジー 胎盤成長因子（ＰｌＧＦ）媒介性の転移および／または血管新生の阻害
JP2013523152A (ja) 2010-04-07 2013-06-17 アントフロゲネシス コーポレーション 胎盤幹細胞を用いる血管形成

Family Cites Families (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
GB1427143A (en) 1972-06-01 1976-03-10 Hodson S A Transfer of freeze-dried specimens
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US4745771A (en) 1983-08-23 1988-05-24 Board Of Regents, The University Of Texas System Apparatus and method for cryopreparing biological tissue for ultrastructural analysis
MX163953B (es) 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
AU6129486A (en) 1985-07-02 1987-01-30 Target Therapeutics, Inc. Vaso-occlusive collagen composition and method
US4847049A (en) 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
EP0290442A4 (en) 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc MEDICINAL PREPARATIONS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS.
US4807442A (en) 1986-12-03 1989-02-28 Board Of Regents The University Of Texas System Cryo-slamming apparatus and method for ultrarapid cooling of biological samples
US4968325A (en) 1987-08-24 1990-11-06 Centre Quebecois De Valorisation De La Biomasse Fluidized bed gasifier
US4964280A (en) 1989-08-17 1990-10-23 Board Of Regents Method and apparatus for cryopreparing biological tissue
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
JPH03176064A (ja) 1989-12-05 1991-07-31 Hoechst Japan Ltd 創面被覆材
DE3942954A1 (de) 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur herstellung von aldehyden
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
KR100195325B1 (ko) 1991-07-10 1999-06-15 구본준 폴리머 제거방법
US5409690A (en) 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
CA2140053C (en) 1994-02-09 2000-04-04 Joel S. Rosenblatt Collagen-based injectable drug delivery system and its use
US7101857B2 (en) 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
DE19719398A1 (de) 1997-05-07 1998-11-12 Amsco Finn Aqua Gmbh Verfahren zur Steuerung eines Gefriertrocknungsprozesses
GB2345638A (en) 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
ATE424181T1 (de) 1999-06-25 2009-03-15 Procter & Gamble Topische antimikrobielle zusammensetzungen
AUPQ196799A0 (en) 1999-08-02 1999-08-26 Pinfold, Ann Method of preservation of amnion and uses thereof
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6893462B2 (en) 2000-01-11 2005-05-17 Regeneration Technologies, Inc. Soft and calcified tissue implants
US6652583B2 (en) 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
KR100377921B1 (ko) 2000-05-04 2003-03-29 정원태 엑시머레이저 각막절제술에서의 안연고 제조방법
US6565960B2 (en) 2000-06-01 2003-05-20 Shriners Hospital Of Children Polymer composite compositions
KR20010000588A (ko) 2000-10-07 2001-01-05 이종훈 통신시스템을 이용한 클립아트 및 고화질 포토이미지다운로드 방법
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2003032735A1 (en) 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
AU2003250666A1 (en) 2002-07-29 2004-02-16 Asahi Kasei Kabushiki Kaisha Stem cells for treating pancreatic damage
WO2004026244A2 (en) 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
WO2004055156A2 (en) 2002-12-17 2004-07-01 Technion Research And Development Foundation Ltd. A vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
WO2005072790A1 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
US7794490B2 (en) 2004-06-22 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices with antimicrobial and biodegradable matrices
EP1796693A2 (en) 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantable tissue compositions and method
KR100622676B1 (ko) 2004-11-24 2006-09-19 합명회사 신흥기업사 풍량제어 하향 송풍식 열풍순환 벌크 건조기
US20060166361A1 (en) 2004-12-21 2006-07-27 Agnieszka Seyda Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
BRPI0611739A2 (pt) 2005-06-10 2011-12-20 Celgene Corp colágeno de atelopeptìdeo, composição, método e kit para aumentar, avolumar ou substituir tecido de um mamìfero, e, processos para preparar e para reticular colágeno de atelopeptìdeo, e para reduzir a quantidade de partìculas virais em uma composição de colágeno
US20070021762A1 (en) 2005-07-13 2007-01-25 Qing Liu Ocular plug formed from placenta derived collagen biofabric
GB0514567D0 (en) 2005-07-15 2005-08-24 Univ Nottingham Surgical membrane
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US20070299043A1 (en) 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
CA2626460A1 (en) 2005-10-18 2007-04-26 Organogenesis, Inc. Antimicrobial collagenous constructs
EP1948259B1 (en) 2005-10-26 2017-03-22 Genesis Technologies Limited Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
US7960165B2 (en) 2005-12-01 2011-06-14 James Wright Method and apparatus for drying organic material
WO2007076522A2 (en) * 2005-12-28 2007-07-05 Ethicon, Incorporated Treatment of peripheral vascular disease using postpartum-derived cells
WO2007083984A1 (en) 2006-01-23 2007-07-26 Gwangju Institute Of Science And Technology Conjugate comprising pharmaceutical active compound covalently bound to mucoadhesive polymer and transmucosal delivery method of pharmaceutical active compound using the same
EP1998742A2 (en) 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
TW200817019A (en) 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
WO2008048663A2 (en) 2006-10-18 2008-04-24 Bacterin International, Inc. Novel process for devitalized/acellular tissue for transplantation
AU2007339257B2 (en) 2006-12-27 2013-01-10 Shriners Hospitals For Children Woven and/or braided fiber implants and methods of making same
US20080233552A1 (en) 2007-03-22 2008-09-25 David Hui-Kang Ma Method of cross-linking amnion to be an improved biomedical material
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
ES2840251T3 (es) 2007-07-10 2021-07-06 Lifecell Corp Composiciones acelulares de matriz tisular para reparación de tejidos
US7856737B2 (en) 2007-08-28 2010-12-28 Mathews Company Apparatus and method for reducing a moisture content of an agricultural product
EP4559488A3 (en) 2007-09-07 2025-08-13 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
US20100317677A1 (en) 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
MX2010003019A (es) 2007-09-19 2010-04-30 Pluristem Ltd Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
WO2009048780A1 (en) 2007-10-08 2009-04-16 The University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
US20090090022A1 (en) 2007-10-09 2009-04-09 Hememics Biotechnologies, Inc. Desiccation Chamber and Methods for Drying Biological Materials
US20110129520A1 (en) 2008-04-25 2011-06-02 Simon Bogdansky Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
US9216077B2 (en) 2008-05-16 2015-12-22 Mimedx Group, Inc. Medical constructs of twisted lengths of collagen fibers and methods of making same
GB0816496D0 (en) 2008-09-10 2008-10-15 Zhao Xiaobin Hyaluronic acid cryogel
WO2010042205A2 (en) 2008-10-09 2010-04-15 Mimedx, Inc. Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches
CN101433556A (zh) 2008-12-05 2009-05-20 成都青山利康药业有限公司 含胎盘成分的保健品组合物及制备方法
WO2010083466A1 (en) 2009-01-16 2010-07-22 Cedars-Sinai Medical Center Methods and compositions for cardiac tissue regeneration
US9393227B2 (en) 2009-02-04 2016-07-19 The Brigham And Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
US20100199514A1 (en) 2009-02-10 2010-08-12 Vermont Organics Reclamation Inc. Optimized apparatus and method for manure management
US20110117171A1 (en) 2009-11-18 2011-05-19 Affinergy, Inc. Implantable bone graft materials
KR101132625B1 (ko) 2010-02-03 2012-04-02 주식회사 바이오랜드 콘택트 렌즈 형태의 양막 드레싱의 제조 방법
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
CA2790436A1 (en) * 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
US20150010609A1 (en) * 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
US20130156863A1 (en) 2010-06-30 2013-06-20 Tissuetech, Inc. Methods of preparing chorion tissue and products derived therefrom
US20120010708A1 (en) 2010-07-08 2012-01-12 AFcell Medical Amnion and chorion replacement cover and uses thereof in surgical repair of muscles
WO2012012410A2 (en) 2010-07-19 2012-01-26 Dr. Reddy's Laboratories Ltd. Kappa opioid receptor agonists
EP2640738A1 (en) 2010-11-15 2013-09-25 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Anti-fungal agents
EP2458043A1 (en) 2010-11-24 2012-05-30 SpinPlant GmbH Product of crosslinked material and method for producing the same
US20120171180A1 (en) 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising amnion derived adherent cells and platelet-rich plasma
US20120189586A1 (en) 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
KR102118457B1 (ko) 2011-02-14 2020-06-03 미메딕스 그룹 인크. 가교제로 변형된 조직 이식편 및 그것의 제조 및 사용 방법
WO2012112410A2 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
KR20140114277A (ko) 2011-02-14 2014-09-26 미메딕스 그룹 인크. 바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
EP3311826B1 (en) 2011-02-14 2020-04-29 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
US8967141B2 (en) 2011-09-14 2015-03-03 Brian Anthony Lemper Inhalation systems, breathing apparatuses, and methods
US12290613B2 (en) 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
TW201315479A (zh) 2011-10-12 2013-04-16 Univ Nat Cheng Kung 可促進動脈新生之醫藥組成物、及其製備方法與應用
WO2013082158A1 (en) 2011-12-02 2013-06-06 Mimedx Group Inc. Shredded tissue grafts and methods for making and using the same
US9186382B2 (en) 2011-12-02 2015-11-17 Mimedx Group, Inc. Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same
CA2857636C (en) 2011-12-22 2020-06-23 Mimedx Group Inc. Cross-linked dehydrated placental tissue grafts and methods for making and using the same
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
WO2013171752A1 (en) 2012-05-16 2013-11-21 Minovia Therapeutics Ltd. Compositions and methods for inducing angiogenesis
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
CA2880157C (en) 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US11338063B2 (en) 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US9446142B2 (en) 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
WO2015109329A1 (en) * 2014-01-17 2015-07-23 Mimedx Group, Inc. Method for inducing angiogenesis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001161353A (ja) 1999-12-09 2001-06-19 Japan Ophthalmic Consultants:Kk 移植用細胞片及びその作成方法
JP2005519101A (ja) 2002-03-05 2005-06-30 ジェイモナト ソシエテ ペル アチオニ Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
JP2005218585A (ja) 2004-02-04 2005-08-18 National Institute For Materials Science 医療用材料及びその製造方法
WO2006025395A1 (ja) 2004-08-31 2006-03-09 Yasuhiko Shimizu キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
JP2008538180A (ja) 2005-03-31 2008-10-16 ステムニオン，インコーポレイテッド 羊膜由来細胞組成物、その作製方法および使用
JP2009514813A (ja) 2005-10-19 2009-04-09 センター フォー モレキュラー メディスン アンド イムノロジー 胎盤成長因子（ＰｌＧＦ）媒介性の転移および／または血管新生の阻害
JP2013523152A (ja) 2010-04-07 2013-06-17 アントフロゲネシス コーポレーション 胎盤幹細胞を用いる血管形成

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Ｃｕｒｒｅｎｔ Ｄｒｕｇ Ｔａｒｇｅｔｓ， ２００８， Ｖｏｌ．９， ｐ．４７－５９
Ｄｉａｂｅｔｅｓ Ｃａｒｅ， １９９８， Ｖｏｌ．２１， Ｎｏ．５， ｐ．８２２－８２７
ＥｐｉＦｉｘ， Ｓｃｉｅｎｔｉｆｉｃ ＆ Ｃｌｉｎｉｃａｌ Ｃｏｍｐｅｎｄｉｕｍ，２０１３年 ３月，ｐ．１－１１
Ｅｘｐｅｒｉｍｅｎｔａｌ Ｎｅｕｒｏｌｏｇｙ， ２０１１， Ｖｏ．２２７， Ｎｏ．１， ｐ．１９５－２０２
Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｗｏｕｎｄ Ｊｏｕｒｎａｌ， ２０１３， Ｖｏｌ．１０， Ｎｏ．５， ｐ．４９３－５００
ＭｉＭｅｄｘ Ｓｃｉｅｎｔｉｆｉｃ Ｓｔｕｄｙ Ｔｏ Ｂｅ Ｐｕｂｌｉｓｈｅｄ Ｉｎ Ｔｈｅ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｗｏｕｎｄ Ｊｏｕｒｎａｌ，ＰＲ Ｎｅｗｓｗｉｒｅ，２０１３，［ｒｅｔｒｉｅｖｅｄ ｏｎ ２０２０．７．２］， Ｒｅｔｒｉｅｖｅｄ ｆｒｏｍ ｔｈｅ Ｉｎｔｅｒｎｅｔ： ＜ＵＲＬ： ｈｔｔｐｓ：／／ｗｗｗ．ｐｒｎｅｗｓｗｉｒｅ．ｃｏｍ／ｎｅｗｓ－ｒｅｌｅａｓｅｓ／ｍｉｍｅｄｘ－ｓｃｉｅｎｔｉｆｉｃ－ｓｔｕｄｙ－ｔｏ－ｂｅ－ｐｕｂｌｉｓｈｅｄ－ｉｎ－ｔｈｅ－ｉｎｔｅｒｎａｔｉｏｎａｌ－ｗｏｕｎｄ－ｊｏｕｒｎａｌ－２１７７３７７８１．ｈｔｍｌ＞
Ｎｉｐｐｏｎ Ｒｉｎｓｈｏ， ２００８， Ｖｏｌ．６６， Ｓｕｐｐｌ．９， ｐ．３９５－３９９
ＴＨＥ ＪＯＵＲＮＡＬ ＯＦ ＪＡＰＡＮＥＳＥ ＣＯＬＬＥＧＥ ＯＦ ＡＮＧＩＯＬＯＧＹ，２００６年，Ｖｏｌ．４６，ｐ．３０５－３１０
ＴＨＥ ＬＡＮＣＥＴ，１９８０年，Ｖｏｌ．１，ｐ．１１５６－１１５７
ＵＮＩＴＥＤ ＳＴＡＴＥＳ ＤＩＳＴＲＩＣＴ ＣＯＵＲＴ ＮＯＲＴＨＥＲＮ ＤＩＳＴＲＩＣＴ ＯＦ ＧＥＯＧＩＡ ＡＴＬＡＮＴＡ ＤＩＶＩＳＩＯＮ， ＣＯＭＰＬＡＩＮＴ ＦＯＲ ＶＩＯＬＡＴＩＯＮＳ ＯＦ ＴＨＥ ＦＥＤＥＲＡＬ ＳＥＣＵＲＩＴＩＥＳ ＬＡＷＳ， ＳＰＥＮＣＥＲ ＡＢＲＡＭＳ ＶＳ ＭＩＭＥＤＸ ＧＲＯＵＰ，２０１３．０９．１４，ｐ．１－３０，［ｒｅｔｒｉｅｖｅｄ ｏｎ ２０１８．１１．１４］， Ｒｅｔｒｉｅｖｅｄ ｆｒｏｍ ｔｈｅ Ｉｎｔｅｒｎｅｔ：＜ＵＲＬ： ｈｔｔｐ：／／ｗｗｗ．ｒｇｒｄｌａｗ．ｃｏｍ／ｍｅｄｉａ／ｃａｓｅｓ／２２９＿Ｃｏｍｐｌａｉｎｔ．ｐｄｆ＞
プラクティス， ２０１１， Ｖｏｌ．２８， Ｎｏ．３， ｐ．２９５－２９９

Also Published As

Publication number Publication date
AU2015206236B2 (en) 2020-02-20
US20210177910A1 (en) 2021-06-17
AU2015206236A1 (en) 2016-07-21
WO2015109329A1 (en) 2015-07-23
EP3094336A1 (en) 2016-11-23
EP3094336A4 (en) 2018-02-14
JP2017507114A (ja) 2017-03-16
US10842824B2 (en) 2020-11-24
US10052351B2 (en) 2018-08-21
US20190022146A1 (en) 2019-01-24
US20150216912A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
JP7464348B2 (ja) 血管新生を誘導する方法
JP7749620B2 (ja) コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法
US11648281B2 (en) Methods for treating cardiac conditions
EP2884844B1 (en) Composition comprising an extract of micronized amnion particles for use in alleviating inflammation in a joint
EP3191145B1 (en) Micronized placental tissue compositions
JP6756612B2 (ja) キレーターを含む微粒子化した胎盤性組成物
US20160051722A1 (en) Mesenchymal Stem Cell-Hydrogel-Biodegradable or Mesenchymal Stem Cell-Hydrogel-Undegradable Support Composition for Skin Regeneration or Wound Healing
US20140140964A1 (en) Compositions and methods for recruiting and localizing stem cells
JP2015534945A (ja) 幹細胞を動員および局在化するための組成物および方法
Palakkara et al. Healing potential of chitosan and decellularized intestinal matrix with mesenchymal stem cells and growth factor in burn wound in rat
US20150283183A1 (en) Methods for treating cardiac conditions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181211

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190306

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190503

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190607

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200403

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200403

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20200421

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200609

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20200616

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20200710

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20200714

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20201124

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20210209

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210430

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210622

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20210720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211014

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20211207

C28A Non-patent document cited

Free format text: JAPANESE INTERMEDIATE CODE: C2838

Effective date: 20211207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220404

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220412

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220606

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220802

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20230307

C28A Non-patent document cited

Free format text: JAPANESE INTERMEDIATE CODE: C2838

Effective date: 20230307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230705

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230804

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230906

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240328

R150 Certificate of patent or registration of utility model

Ref document number: 7464348

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150